MARKET

LTRN

LTRN

Lantern Pharma Inc
NASDAQ
2.060
-0.030
-1.44%
Closed 16:10 05/12 EDT
OPEN
2.050
PREV CLOSE
2.090
HIGH
2.155
LOW
2.000
VOLUME
151.78K
TURNOVER
0
52 WEEK HIGH
5.74
52 WEEK LOW
1.110
MARKET CAP
23.29M
P/E (TTM)
-1.3114
1D
5D
1M
3M
1Y
5Y
1D
Lantern Pharma schedules first-quarter results update
PUBT · 1d ago
Lantern Pharma to Report First Quarter 2026 Operating & Financial Results on May 15th, 2026
Barchart · 1d ago
Weekly Report: what happened at LTRN last week (0504-0508)?
Weekly Report · 2d ago
Lantern Pharma unveils roadmap for withZeta.ai
TipRanks · 5d ago
Lantern Pharma plans ZetaSwarm, ZetaOmics additions to withZeta.ai in coming year
PUBT · 5d ago
Weekly Report: what happened at LTRN last week (0427-0501)?
Weekly Report · 05/04 09:16
Lantern Pharma announces expansion of predictBBB.ai into LQM
TipRanks · 04/29 13:54
Lantern Pharma Expands Its predictBBB.ai Web Service Into A Large Quantitative Model
Benzinga · 04/29 12:56
More
About LTRN
Lantern Pharma Inc. is an artificial intelligence (AI) company. The Company is developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, leverages over 100 billion oncology-focused data points and a library of over 200+ advanced ML algorithms to help solve problems in oncology drug development. It is engaged in the development of its pipeline of therapies that span multiple cancer indications, including both solid tumors and blood cancers and an antibody drug conjugate (ADC) program. It has active clinical programs for its three lead small molecule drug candidates: LP-300, LP-184, and LP-284. These programs are focused on multiple cancer indications, including both solid tumors and blood cancers. It is also focused on the clinical execution of its therapies for CNS and brain cancers through Starlight Therapeutics Inc.

Webull offers Lantern Pharma Inc stock information, including NASDAQ: LTRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LTRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LTRN stock methods without spending real money on the virtual paper trading platform.